800-551-0488

Lab results are too important to go anywhere else

Beaumont Laboratory

HTLV I/II Antibodies with Reflex to Confirmation

HTLV I/II Western Blot, ARUP# 51164, EPIC: LAB6059, SOFT: XHTLV

Instructions

Patients with positive results by ELISA will reflex to confirmation by Western Blot.

Specimen Collection Criteria

Collect (preferred specimen): One Gold-top SST tube.
Also acceptable: One plain Red-top tube, Lavender-top EDTA tube, Green-top Sodium or Lithium Heparin tube, or Light Blue-top Sodium Citrate tube.

Send specimen for processing immediately after collection.

Physician Office/Drawsite Specimen Preparation

Centrifuge to separate serum or plasma from cells within two hours of collection. Transfer serum or plasma to a plastic transport tube and refrigerate (2-8°C or 36-46°F) immediately.

Preparation for Courier Transport

Transport: 1.0 mL serum or plasma, refrigerated (2-8°C or 36-46°F). (Min: 0.5 mL)

Rejection Criteria

  • Specimens not collected and processed as indicated.

Storage

Specimen Stability for Testing:

Room Temperature (20-26°C or 68-78.8°F): Unacceptable
Refrigerated (2-8°C or 36-46°F): 7 days
Frozen (-20°C/-4°F or below): Indefinitely

Specimen Storage in Department Prior to Disposal:

Specimen retention time is determined by the policy of the reference laboratory. Contact the Sendout Laboratory with any questions.

Laboratory

Sent to ARUP Laboratories, Salt Lake City, UT.

Performed

Monday, Wednesday, Friday.
Results available in 2-6 days.

Reference Range

Negative.

Test Methodology

Qualitative Enzyme-Linked Immunosorbent Assay/Qualitative Western Blot.

Interpretation

ARUP intends use of this assay for clinical diagnosis. This assay should not be considered for blood donor screening or associated re-entry protocols.

Clinical Disease

Human T-Cell Lymphotropic Virus-1 (HTLV-1) has been associated with adult T-cell leukemia (ATL) and may play an indirect role in the pathocenesis of some B-cell chronic lymphocytic leukemia (CLL) cases. HTLV-1 has also been associated with chronic neurologic diseases including tropical spastic paraparesis (TSP) and HTLV-associated myelopathy (HAM). (1)

Disease Reporting

This is a reportable infection and positive results will be reported to the Oakland County Health Department. For more information on reportable diseases, contact the Epidemiology Department at (248) 551-4040.

Epidemiology

HTLV-1 is primarily endemic in southwestern Japan and the Caribbean, however, parts of sub-Saharan Africa and Central and South America also have significant seroprevalence. Increased seropositivity has been observed in the Southwestern United States, the United Kingdom, and in countries with large Caribbean populations. Approximately 0.1% of males and 0.2% of females infected at childhood develop ATL as adults. HTLV-1 appears to have very little genetic variability. (1)

Incubation Period

10-30 years. Infection is assumed to be lifelong. HTLV-1 associated myelopathy sometimes develops just a few years after infection. (1)

Transmission

HTLV-1 is poorly contagious and transmission can occur via blood transfusion, contaminated needles, sexual contact, and from mother to child through breast feeding. (1)

Reference

  1. Wiedbrauk D, Johnston SLG. Manual of Clinical Virology, Raven Press, New York, NY, 1993.

CPT Code

86790, (86689 if indicated for confirmation).

Test Codes

ARUP# 51164, EPIC: LAB6059, SOFT: XHTLV

Last Updated

09/14/2016

Microtainer® and Vacutainer® are registered trademarks of Becton, Dickinson and Company.
UroVysion® is a registered trademark of Abbott Laboratories. ThinPrep® is a registered trademark of Hologic, Incorporated.

This directory currently reflects information only for specimens collected and/or processed at the Farmington Hills, Grosse Pointe, Royal Oak, and Troy campuses.